Literature DB >> 20101519

Effects of phenylalanine on the survival and neurite outgrowth of rat cortical neurons in primary cultures: possible involvement of brain-derived neurotrophic factor.

Duan Li1, Xuefan Gu, Lihua Lu, Lili Liang.   

Abstract

Phenylketonuria (PKU) is characterized by elevated levels of phenylalanine (Phe) in plasma and cerebrospinal fluid of PKU patients, leading to mental retardation. The developmental delay in the cerebral cortex is one of the characteristic pathologic changes in untreated phenylketonuria patients. This is thought to be due to the toxic effects of Phe and/or its metabolites; however, the underlying mechanisms are as yet unknown. In this study, using a model system in which cultured cortical neurons were induced with Phe, we observed that Phe inhibited the longest neurite outgrowth and induced the neuronal death. We further demonstrated that the expression of BDNF mRNA and protein was significantly decreased by Phe, together with a decrease in extracellular signal-regulated kinase (ERK) and Akt phosphorylation activity. There was no change in expression of TrkB mRNA and protein. Considering the important role of BDNF in normal brain development and function, these L: -Phe-induced changes in BDNF in PKU brain may be a critical element of the neurological symptoms of PKU.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20101519     DOI: 10.1007/s11010-009-0364-2

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  41 in total

1.  Identification of the mechanisms regulating the differential activation of the mapk cascade by epidermal growth factor and nerve growth factor in PC12 cells.

Authors:  S Kao ; R K Jaiswal; W Kolch; G E Landreth
Journal:  J Biol Chem       Date:  2001-03-13       Impact factor: 5.157

2.  Opposing roles for endogenous BDNF and NT-3 in regulating cortical dendritic growth.

Authors:  A K McAllister; L C Katz; D C Lo
Journal:  Neuron       Date:  1997-05       Impact factor: 17.173

3.  Evidence for central nervous system glial cell plasticity in phenylketonuria.

Authors:  C A Dyer; A Kendler; T Philibotte; P Gardiner; J Cruz; H L Levy
Journal:  J Neuropathol Exp Neurol       Date:  1996-07       Impact factor: 3.685

4.  Is there a relationship between 3-hydroxy-3-methylglutaryl coenzyme a reductase activity and forebrain pathology in the PKU mouse?

Authors:  S Shefer; G S Tint; D Jean-Guillaume; E Daikhin; A Kendler; L B Nguyen; M Yudkoff; C A Dyer
Journal:  J Neurosci Res       Date:  2000-09-01       Impact factor: 4.164

5.  Effects of phenylalanine and its metabolites on cytoplasmic free calcium in cortical neurons.

Authors:  Y G Yu; F G Tang; J Pan; X F Gu
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 3.996

6.  Experimental hyperphenylalaninemia provokes oxidative stress in rat brain.

Authors:  Martine E Kienzle Hagen; Carolina D Pederzolli; Angela M Sgaravatti; Raquel Bridi; Moacir Wajner; Clóvis M D Wannmacher; Angela T S Wyse; Carlos S Dutra-Filho
Journal:  Biochim Biophys Acta       Date:  2002-04-24

7.  Long-term changes in glutamatergic synaptic transmission in phenylketonuria.

Authors:  A V Glushakov; O Glushakova; M Varshney; L K Bajpai; C Sumners; P J Laipis; J E Embury; S P Baker; D H Otero; D M Dennis; C N Seubert; A E Martynyuk
Journal:  Brain       Date:  2005-01-05       Impact factor: 13.501

8.  Cerebral energy metabolism in phenylketonuria: findings by quantitative In vivo 31P MR spectroscopy.

Authors:  Joachim Pietz; André Rupp; Friedrich Ebinger; Dietz Rating; Ertan Mayatepek; Chris Boesch; Roland Kreis
Journal:  Pediatr Res       Date:  2003-02-20       Impact factor: 3.756

9.  Insulin neuroprotection against oxidative stress is mediated by Akt and GSK-3beta signaling pathways and changes in protein expression.

Authors:  Ana I Duarte; Paulo Santos; Catarina R Oliveira; Maria S Santos; A Cristina Rego
Journal:  Biochim Biophys Acta       Date:  2008-02-29

10.  Phenylalanine reduces synaptic density in mixed cortical cultures from mice.

Authors:  Friederike Hörster; Marina A Schwab; Sven W Sauer; Joachim Pietz; Georg F Hoffmann; Jürgen G Okun; Stefan Kölker; Stefan Kins
Journal:  Pediatr Res       Date:  2006-04       Impact factor: 3.756

View more
  9 in total

1.  AMP-activated protein kinase activation in mediating phenylalanine-induced neurotoxicity in experimental models of phenylketonuria.

Authors:  Lihua Lu; Xiaoming Ben; Lingling Xiao; Min Peng; Yongjun Zhang
Journal:  J Inherit Metab Dis       Date:  2017-12-11       Impact factor: 4.982

Review 2.  Oxidative stress in phenylketonuria-evidence from human studies and animal models, and possible implications for redox signaling.

Authors:  Vanessa Trindade Bortoluzzi; Carlos Severo Dutra Filho; Clovis Milton Duval Wannmacher
Journal:  Metab Brain Dis       Date:  2021-02-13       Impact factor: 3.584

3.  Generation of urine-derived induced pluripotent stem cells from a patient with phenylketonuria.

Authors:  Zijuan Qi; Yazhou Cui; Liang Shi; Jing Luan; Xiaoyan Zhou; Jinxiang Han
Journal:  Intractable Rare Dis Res       Date:  2018-05

4.  Doxycycline hinders phenylalanine fibril assemblies revealing a potential novel therapeutic approach in phenylketonuria.

Authors:  Ada De Luigi; Alessandro Mariani; Massimiliano De Paola; Andrea Re Depaolini; Laura Colombo; Luca Russo; Valeria Rondelli; Paola Brocca; Lihi Adler-Abramovich; Ehud Gazit; Elena Del Favero; Laura Cantù; Mario Salmona
Journal:  Sci Rep       Date:  2015-10-29       Impact factor: 4.379

5.  The Behavioral Consequence of Phenylketonuria in Mice Depends on the Genetic Background.

Authors:  Vibeke M Bruinenberg; Els van der Goot; Danique van Vliet; Martijn J de Groot; Priscila N Mazzola; M Rebecca Heiner-Fokkema; Martijn van Faassen; Francjan J van Spronsen; Eddy A van der Zee
Journal:  Front Behav Neurosci       Date:  2016-12-20       Impact factor: 3.558

6.  Metabolomics analysis reveals perturbations of cerebrocortical metabolic pathways in the Pahenu2 mouse model of phenylketonuria.

Authors:  Li-Hua Lu; Zheng-Xiang Xia; Jia-Lin Guo; Ling-Ling Xiao; Yong-Jun Zhang
Journal:  CNS Neurosci Ther       Date:  2019-08-31       Impact factor: 5.243

Review 7.  Prenatal Drugs and Their Effects on the Developing Brain: Insights From Three-Dimensional Human Organoids.

Authors:  Isidora N Stankovic; Dilek Colak
Journal:  Front Neurosci       Date:  2022-03-25       Impact factor: 4.677

8.  The Fas/Fas ligand death receptor pathway contributes to phenylalanine-induced apoptosis in cortical neurons.

Authors:  Xiaodong Huang; Zhaohui Lu; Zhongwei Lv; Tingting Yu; Peirong Yang; Yongnian Shen; Yu Ding; Da Fu; Xiaoping Zhang; Qihua Fu; Yongguo Yu
Journal:  PLoS One       Date:  2013-08-07       Impact factor: 3.240

9.  Altered brain protein expression profiles are associated with molecular neurological dysfunction in the PKU mouse model.

Authors:  Esther Imperlini; Stefania Orrù; Claudia Corbo; Aurora Daniele; Francesco Salvatore
Journal:  J Neurochem       Date:  2014-03-24       Impact factor: 5.372

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.